Bionano Genomics, Inc. Business Combination, Contingent Consideration, Liability, Current
Bionano Genomics, Inc. (BNGO) had Business Combination, Contingent Consideration, Liability, Current of $0 as of 2023-12-31, per its 10-K filed 2024-03-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2024-03-05
- 2023-12-31: Business Combination, Contingent Consideration, Liability, Current $0.00.
- 2023-09-30: Business Combination, Contingent Consideration, Liability, Current $10.00M.
- 2023-06-30: Business Combination, Contingent Consideration, Liability, Current $10.00M.
- 2023-03-31: Business Combination, Contingent Consideration, Liability, Current $9.46M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-05 |
| 2023-09-30 | $10.00M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $10.00M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $9.46M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $9.38M 10-K · filed 2024-03-05 |
| 2022-09-30 | $9.30M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $9.22M 10-Q · filed 2022-08-04 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |